161 related articles for article (PubMed ID: 32485321)
1. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy.
Khan MM; Madni A; Filipczak N; Pan J; Rehman M; Rai N; Attia SA; Torchilin VP
Nanomedicine; 2020 Aug; 28():102228. PubMed ID: 32485321
[TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
[TBL] [Abstract][Full Text] [Related]
3. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
4. Folate-modified, indocyanine green-loaded lipid-polymer hybrid nanoparticles for targeted delivery of cisplatin.
Gu L; Shi T; Sun Y; You C; Wang S; Wen G; Chen L; Zhang X; Zhu J; Sun B
J Biomater Sci Polym Ed; 2017 May; 28(7):690-702. PubMed ID: 28277002
[TBL] [Abstract][Full Text] [Related]
5. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
6. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
8. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer.
Khan S; Madni A; Shah H; Jan N; Shafiq A; Basit A; Rai N; Ali A; Khan MM
Int J Biol Macromol; 2022 Dec; 222(Pt A):497-508. PubMed ID: 36174854
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
10. Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.
Mollarazi E; Jalilian AR; Johari-Daha F; Atyabi F
J Labelled Comp Radiopharm; 2015 Jun; 58(8):327-35. PubMed ID: 26036233
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
[TBL] [Abstract][Full Text] [Related]
13. Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
Geethakumari D; Bhaskaran Sathyabhama A; Raji Sathyan K; Mohandas D; Somasekharan JV; Thavarool Puthiyedathu S
Int J Biol Macromol; 2022 Feb; 199():150-161. PubMed ID: 34973988
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
[TBL] [Abstract][Full Text] [Related]
16. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Liu Y; Li K; Pan J; Liu B; Feng SS
Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
[TBL] [Abstract][Full Text] [Related]
17. Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy.
Gaspar VM; Costa EC; Queiroz JA; Pichon C; Sousa F; Correia IJ
Pharm Res; 2015 Feb; 32(2):562-77. PubMed ID: 25186437
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells.
Yang SJ; Lin FH; Tsai KC; Wei MF; Tsai HM; Wong JM; Shieh MJ
Bioconjug Chem; 2010 Apr; 21(4):679-89. PubMed ID: 20222677
[TBL] [Abstract][Full Text] [Related]
19. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK
Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX
Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
